Product Information

DEXMETHYLPHENIDATE ER 30 MG CP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.4363 per EA under NDC 31722023401. Its NADAC has been published 232 times since Jun 8, 2022.

FDA first approved this application on Dec 8, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DEXMETHYLPHENIDATE ER 30 MG CP

dexmethylphenidate hydrochloride
$1.4363per EA
DEA Schedule CII

Strength

30 mg/1

NDC

31722023401

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215523

FDA Approved

12/8/2021

TE Code

AB

On Market Since

12/8/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has been published 232 times since Jun 8, 2022, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4363 per EA
All-time high$2.4994 (Nov 13, 2024)
All-time low$0.7499 (May 22, 2024)
52-week high$1.8223
52-week low$1.4363
Median price$1.7109
Average price$1.6706
Largest weekly change+75.7% (Jun 19, 2024)
Weeks tracked232
Tracking sinceJun 8, 2022

Price History

1W

0.0%

1M

-7.9%

3M

-18.5%

6M

-11.1%

1Y

-16.0%

3Y

-38.3%

5Y

N/A

All

-12.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DEXMETHYLPHENIDATE ER 30 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE ER 30 MG CP, manufactured by Camber Pharmaceuticals Inc., is $1.4363 per EA (NDC 31722023401), effective Nov 11, 2026.

How has the price of DEXMETHYLPHENIDATE ER 30 MG CP changed over time?

Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has declined 12.2%. It has been tracked across 232 weekly CMS publications since Jun 8, 2022.

What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE ER 30 MG CP?

Since Jun 8, 2022, the NADAC for DEXMETHYLPHENIDATE ER 30 MG CP has ranged from a low of $0.7499 (May 22, 2024) to a high of $2.4994 (Nov 13, 2024), with a median of $1.7109 per EA.

Are there cheaper alternatives to DEXMETHYLPHENIDATE ER 30 MG CP?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE ER 30 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures DEXMETHYLPHENIDATE ER 30 MG CP?

DEXMETHYLPHENIDATE ER 30 MG CP (NDC 31722023401) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.